Skip to main content

Day: November 18, 2020

Grey Cloak Tech Inc. Announces Strategic Equity Investment from the Medical Community

LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Grey Cloak Tech Inc. (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary development of natural plant-based formulations as well as sales and distribution of clinically proven cardiovascular and neuro products, announces a recent investment from four additional physicians for equity in the company.“Healthy Extracts Inc. continues to see a growing number of practitioners in the medical community endorsing our exclusive Citrus Bergamot SuperFruit™ and Fuel4thought™ products, utilized for heart and brain health,” said CEO Duke Pitts.Through its Ultimate Brain Nutrients (“UBN”) subsidiary, Grey Cloak Tech has four unique patent-pending formulations, with one patent issued. These formulations increase brain...

Continue reading

Gen III hires Blue Deer Capital Partners and provides general update

VANCOUVER, British Columbia, Nov. 18, 2020 (GLOBE NEWSWIRE) — Gen III Oil Corporation (“Gen III” or the “Company”) (TSX-V: GIII) (OTCQX: ISRJF) is pleased to announce that effective November 18, 2020 the Company has hired Blue Deer Capital Partners (“Blue Deer”) for an initial term expiring December 31, 2021, to provide non-exclusive financial advisory services for a monthly fee. The Company has also agreed to issue 1,000,000 fully vested options to Blue Deer, with an exercise price of $0.30/share, valid for a period of 18 months.Further to the Company’s announcement on November 5, 2020, Gen III continues to work with the Super Major (“SM”) towards completion of the Definitive Agreement and the SM has also begun assisting the Company with its review of suitable re-refinery sites in the US Gulf Coast region.About Blue...

Continue reading

Genco Shipping & Trading Limited Announces Participation in Noble Capital Markets C-Suite Interview Series

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK), the largest U.S. headquartered drybulk shipowner focused on the transportation of major and minor bulk commodities globally, today announced its participation in Noble Capital Markets’ C-Suite Interview Series, presented by Channelchek.The interview was led by Noble Capital Markets Senior Research Analyst Poe Fratt. Joining Poe was John Wobensmith, Chief Executive Officer of Genco Shipping & Trading Limited. Key topics discussed in this interview include:Macro outlook for industry recovery – Managing through the volatilityRegulatory outlook and possible changesGenco’s fleet renewal program strategyManaging crew changes amidst Covid pandemicScrubbers – Benefits achieved for Capes to dateGreatest challenges and opportunities going...

Continue reading

Generex Inks $50 Million Licensing Deal with China Partners on the Cooperative Development of the Ii-Key Vaccine Platform

$50 million licensing deal for the Ii-Key platform to develop vaccines for infectious diseases and cancerDeal includes first contract for Ii-Key- SARS-CoV-2 vaccine against COVID-19 in China with a $5 million upfront licensing fee, 100% funding for manufacturing, development and commercial registration and a $20 million success fee for approval Ii-Key- SARS-CoV-2 vaccine in ChinaRoyalty payments for COVID vaccine with billion-dollar royalty potentialFramework agreement for the development of additional Ii-Key vaccines for cancer & infectious diseases under separate licensing deals with fees, milestones, and royalties on salesAn 8K will be filed on the contract todayMIRAMAR, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is...

Continue reading

Stifel Names Veteran Fire & Security Industry Executive Dean Seavers as Senior Advisor

ST. LOUIS, Nov. 18, 2020 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced an agreement with Dean Seavers, former U.S. President and Executive Director of National Grid, to serve as a senior advisor. He will work with Stifel professionals across industry verticals, with a primary focus on Business and Utility Services.Most recently, Mr. Seavers was President and Executive Director of National Grid, where he led a business transformation focused on financial performance, safety, and employee engagement. He previously was Co-Founder and CEO of Red Hawk Fire & Security, now part of ADT Security Services. Under his leadership, Red Hawk grew to become the second-largest independent fire and security platform in the U.S., providing fire and integrated security solutions to large and mid-sized commercial customers.Mr....

Continue reading

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

PDUFA date remains February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patientsBERKELEY HEIGHTS, N.J., Nov. 18, 2020 (GLOBE NEWSWIRE) — CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that the U.S. Food and Drug Administration (FDA) has decided to cancel the Antimicrobial Drug Advisory Committee meeting tentatively scheduled for January 14, 2021 to discuss the New Drug Application (NDA) for Defencath®. When the FDA accepted for filing the Company’s submitted NDA and granted priority review, it set a Prescription Drug User Fee Act (PDUFA) date of February 28, 2021...

Continue reading

FluroTech Announces Stadium and Arena Product Solution

CALGARY, Alberta, Nov. 18, 2020 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product solution aimed at solving the testing problems facing the operators of large stadiums, arenas, and other high capacity venues.The FluroTest stadium and arena product solution is a COVID testing platform capable of running 3,000 tests per hour directly at the point of collection with results immediately available to every test taker within 5 minutes. This enables the safe opening of stadiums, arenas, airports, and other high traffic environments. Platforms can be configured to open any 60,000-seat indoor arena or outdoor stadium to full capacity in less than 2 hours.“We applaud this week’s Ticketmaster COVID-19 Announcement. This is a...

Continue reading

KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event

Online Event Scheduled for Wednesday, December 2, 2020 at 10:00 a.m., ETCELEBRATION, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) — KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that it will co-host an online investor event with Corium, Inc. to discuss the potential commercialization strategy for KP415 and the anticipated opportunity for the drug product as a potential new entry into the attention deficit hyperactivity disorder (ADHD) marketplace if approved by the U.S. Food and Drug Administration (FDA). The online event will be held on Wednesday, December 2, 2020, beginning at 10:00 a.m., ET.The event will feature speakers from KemPharm, Corium, and Ann Childress, M.D., President of the Center for Psychiatry and Behavioral Medicine. The...

Continue reading

BlueCity to Report Third Quarter 2020 Unaudited Financial Results on Wednesday, December 2, 2020

BEIJING, Nov. 18, 2020 (GLOBE NEWSWIRE) — BlueCity Holdings Limited (“BlueCity” or the “Company”) (NASDAQ: BLCT), a world’s leading online LGBTQ platform, today announced that it will report its third quarter 2020 unaudited financial results on Wednesday, December 2, 2020, before the open of U.S. market.BlueCity’s management team will host an earnings conference call at 8:00 AM on Wednesday, December 2, 2020, U.S. Eastern Time (9:00 PM on December 2, 2020, Beijing/Hong Kong Time).Please register in advance of the conference using the link provided below. Conference access information will be provided upon registration.Participant Online Registration: http://apac.directeventreg.com/registration/event/3483656A replay of the conference call may be accessed by phone at the following numbers until December 10, 2020. To access the...

Continue reading

Logiq Launches Pilot Program to Provide Mobile Fintech Services in Exclusive Strategic Alliance with Indonesian National Cooperative, KMSB

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) —  Logiq, Inc. (OTCQX: LGIQ), a global provider of award-winning eCommerce and fintech solutions, has launched its previously announced micro-lending pilot program in an exclusive strategic alliance with the country’s social security program provider, Koperasi Mona Santoso Berjaya (KMSB).Logiq and KMSB have agreed to jointly own and operate a new mobile fintech platform that will deliver mobile financial services. Logiq, through its Indonesian operations, will provide platform design and technology, management, ongoing hosting and technical support. KMSB will provide the financial institutional relationships for enabling the microlending program. The partners will then work together to launch a new marketing and advertising campaign that will encourage adoption and regular use of the mobile...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.